Could junk food fuel eczema in kids?
NCT ID NCT06996327
First seen Sep 01, 2026 · Last updated Sep 02, 2026 · Updated 1 time
Summary
This study investigates whether compounds found in ultra-processed foods, like advanced glycation end products (AGEs), might play a role in childhood eczema, also known as atopic dermatitis. Researchers will compare the diets of 100 children aged 6 months to 10 years, half with eczema and half without, to see if those with the condition consume more of these foods. The goal is to understand if dietary habits could be a hidden trigger for this common skin condition.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Dietary assessment of ultra-processed foods and advanced glycation end products (AGEs)
- What this could lead to
- If a link is found, it could point to dietary changes as a way to help manage or prevent eczema flare-ups in children.
- What could go wrong
- This is an observational study, so it cannot prove cause and effect. The results may be influenced by other factors, and the findings may not apply to all children.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
100 people
The number who actually took part.
- Started
-
Jan 2024
- Finished
-
Jan 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Caucasian subjects of both sexes, aged ≥6 and ≤10 years, with a diagnosis of atopic dermatitis, and healthy controls matched for age and sex without atopic dermatitis, recruited from the Pediatric Outpatient Clinics of the University Hospital "Federico II".
- Ages
-
6 months to 10 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Caucasian subjects, both sexes, age: ≥6 months and ≤10 years, with a confirmed diagnosis of atopic dermatitis, and healthy controls matched for age and sex without atopic dermatitis; * Written informed consent obtained from the participants and/or their parents/legal guardians. Exclusion Criteria: * Non-Caucasian ethnicity; age \< 6 or \> 10 years * Presence of other chronic conditions: hypereosinophilic syndrome, fungal or viral infections, connective tissue disorders, autoimmune diseases, vasculitis, bullous dermatoses (e.g., pemphigus), drug hypersensitivity reactions, graft-versus-host disease, monogenic disorders (e.g., Marfan syndrome type 2, Hyper-IgE syndrome) * Presence of scars, nevi, or unusual skin lesions on both forearms * Absence of written informed consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Atopic dermatitis are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Traslational Medical Science - University of Naples Federico II
Naples, Naples, 80131, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an eczema drug reshape the Skin's microbial community?
- Can a pill tame severe eczema? a new trial puts QX-4533 to the test
- Can a probiotic soothe Children's eczema?
- Can a daily pill calm severe eczema from the inside?
- Can we predict the path of chronic skin disease?
- Which eczema drug wins? a Head-to-Head test aims to find out